CompletedNot Applicable

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

China20 participantsStarted 2023-01-29

Plain-language summary

The purpose of this study is to test whether spraying the hand of patients by use of the novel electrolyzed water spray will decrease the number of bacteria E-coli and the virus titer of an attenuated human flu virus.

Who can participate

Age range24 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-60 years.
✓. Male or female of any race and ethnicity.
✓. Subject agrees to comply with study requirements.

Exclusion criteria

✕. Severely unhealthy participants.
✕. 80 years or older.
✕. Subjects with severe medical condition(s) that in the view of the investigator prohibits participation in the study.
✕. Dermatologic disease such as psoriasis or atopic dermatitis which may have inherently abnormal antimicrobial peptide levels.
✕. Subject has Netherton's syndrome or other genodermatoses that result in a defective epidermal barrier.
✕. Immunocompromised subjects, or with a history of active or malignant disease as determined by the participant's medical history.
✕. Subjects with a history of psychiatric disease or history of alcohol or drug abuse that would interfere with the ability to comply with the study protocol.
✕. Subjects with significant concurrent medical condition(s) at screening that in the view of the investigator prohibits participation in the study

What they're measuring

Flush and eradicate the number of bacteria E-coli on human hands.

Timeframe: 10 seconds

Trial details

NCT IDNCT05797103

SponsorDove Medical Press Ltd

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2023-07-02

View on ClinicalTrials.gov More Bacterial Growth trials